CD4 and COVID-19: T-cell lymphopenia, particularly the CD4+ T-lymphocyte subset, and an increased neutrophil to lymphocyte ratio (NLR) (indicator of inflammation) has also been observed in COVID-19 patients and correlates with disease severity (34).